Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Perinatology

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/jp.2010.199PMID 21252965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

  2013cited by this paper
• Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?

  2010cited by this paper
• Safety and Effectiveness of Indomethacin versus Ibuprofen for Treatment of Patent Ductus Arteriosus

  2009cited by this paper
• Understanding Intestinal Vulnerability to Perforation in the Extremely Low Birth Weight Infant

  2009cited by this paper
• Understanding Clinical Literature Relevant to Spontaneous Intestinal Perforations

  2008cited by this paper
• An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.

  2008cited by this paper
• Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity

  2007cited by this paper
• Patent ductus arteriosus: lack of evidence for common treatments

  2007cited by this paper
• Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?

  2007cited by this paper
• Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial

  2007cited by this paper
• Discharge outcomes of extremely low birth weight infants with spontaneous intestinal perforations

  2006cited by this paper
• New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations

  2006cited by this paper
• Attridge et al. present an analysis of a complex data set, which offers important confirmation of the differences between the clinical presentation of spontaneous intestinal perforations (SIP) and surgical necrotizing enterocolitis (NEC).

  2006cited by this paper
• Systematic review: intravenous Ibuprofen in preterm newborns.

  2006cited by this paper
• New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure

  2006cited by this paper
• Prevalence of Spontaneous Closure of the Ductus Arteriosus in Neonates at a Birth Weight of 1000 Grams or Less

  2006cited by this paper
• Postoperative Outcomes of Extremely Low Birth-Weight Infants With Necrotizing Enterocolitis or Isolated Intestinal Perforation: A Prospective Cohort Study by the NICHD Neonatal Research Network

  2005cited by this paper
• Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial

  2004cited by this paper
• Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial.

  2004cited by this paper
• Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very‐low‐birthweight infants

  2004cited by this paper
• Prevention of intraventricular hemorrhage by indomethacin in male preterm infants.

  2004cited by this paper
• Necrotizing Enterocolitis and Gastrointestinal Complications After Indomethacin Therapy and Surgical Ligation in Premature Infants With Patent Ductus Arteriosus

  2003cited by this paper
• Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis

  2003cited by this paper
• Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

  2002cited by this paper
• 超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント)

  2001cited by this paper
• The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials.

  2001cited by this paper
• Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.

  2001cited by this paper
• A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.

  2000cited by this paper
• Indomethacin-associated bowel perforations: a study of possible risk factors.

  1999cited by this paper
• Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.

  1996cited by this paper
• Focal intestinal perforation in the extremely-low-birth-weight infant.

  1994cited by this paper
• Spontaneous focal gastrointestinal perforation in very low birth weight infants.

  1988cited by this paper
• Localized intestinal perforations after enteral administration of indomethacin in premature infants.

  1985cited by this paper
• Gastrointestinal perforation following indomethacin therapy in very low birth weight infants.

  1981cited by this paper

• Use of NSAIDs and acetaminophen and risk of spontaneous intestinal perforations in premature infants: a systematic review and meta-analysis

  2024cites this paper
• Early Treatment of Patent Ductus Arteriosus with Ibuprofen. Reply.

  2024cites this paper
• Title : Intestinal microbiome changes in an infant with right atrial isomerism and recurrent necrotizing enterocolitis : A case report

  2022cites this paper
• Patent ductus arteriosus and spontaneous intestinal perforation in a cohort of preterm infants

  2022cites this paper
• Acetaminophen Therapy for Persistent Patent Ductus Arteriosus.

  2021cites this paper
• Comparison of the effect of continuous and standard intermittent bolus paracetamol infusion on patent ductus arteriosus

  2020cites this paper
• Adverse events related to ibuprofen treatment for patent ductus arteriosus in premature neonates.

  2020cites this paper
• Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis

  2020cites this paper
• Congenital Heart Defects, Heart Surgeries, Low Cardiac Output Syndrome

  2020cites this paper
• Paracetamol treatment for patent ductus arteriosus: practice and attitudes in Australia and New Zealand

  2019cites this paper
• Tratamiento farmacológico del conducto arterioso permeable en recién nacidos prematuros

  2019cites this paper
• Risk factors for spontaneous localized intestinal perforation in the preterm infant

  2018cites this paper
• Effect on cerebral oxygenation of paracetamol for patent ductus arteriosus in preterm infants

  2018cites this paper
• Multi-hit hypothesis in kidney development: Drug effects and interactions with extrauterine growth restriction

  2016cites this paper
• Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial

  2016cites this paper
• Revisión y actualización de enterocolitis necrosante

  2015cites this paper
• Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.

  2015cites this paper
• Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications.

  2014cites this paper
• Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants

  2014cites this paper
• Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial

  2013cites this paper
• Pharmacological Management of PDA: oral versus intravenous medications.

  2012cites this paper
• Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants

  2012cites this paper
• Patent Ductus Arteriosus in Premature Neonates

  2012cites this paper
• Ibubrofen in the treatment of patent ductus arteriosus in preterm infants: what we know, what we still do not know.

  2012cites this paper
• Current evidence on the safety profile of NSAIDs for the treatment of PDA

  2011cites this paper
• Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants

  2011cites this paper